Safety and Efficacy of the Selective Costimulation Modulator Abatacept in Patients With Rheumatoid Arthritis Receiving Background Methotrexate: A 5-Year Extended Phase IIB Study
Journal of Rheumatology - Canada
doi 10.3899/jrheum.080813
Full Text
Open PDFAbstract
Available in full text
Date
February 27, 2009
Authors
Publisher
The Journal of Rheumatology